- Home
- NMFC vs ETON Comparison
NMFC vs ETON Comparison
Compare NMFC & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMFC | ETON |
|---|---|---|
| Founded | 2010 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 796.4M | 683.7M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | NMFC | ETON |
|---|---|---|
| Price | $7.98 | $26.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $8.63 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 1.2M | 450.4K |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | ★ 16.20% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $79,950,000.00 |
| Revenue This Year | N/A | $40.90 |
| Revenue Next Year | N/A | $47.23 |
| P/E Ratio | $12.51 | ★ N/A |
| Revenue Growth | N/A | ★ 104.94 |
| 52 Week Low | $7.47 | $12.25 |
| 52 Week High | $11.04 | $27.19 |
Technical Indicators
Market Signals| Indicator | NMFC | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 52.60 | 70.78 |
| Support Level | $7.91 | $16.79 |
| Resistance Level | $8.28 | N/A |
| Average True Range (ATR) | 0.21 | 1.33 |
| MACD | 0.05 | 0.18 |
| Stochastic Oscillator | 71.23 | 79.02 |
Price Performance
Historical ComparisonAbout NMFC New Mountain Finance Corporation
New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds and mezzanine securities.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.